Press Releases
AbbVies Inc Leadership in Gastroenterology Showcased at Digestive Disease...
Data presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate to severe Crohn's disease in adult and pediatric patients. ...
Press Releases
Bayer AG to Showcase Latest Oncology Research at ASCO...
Bayer announced that data from several studies across its oncology portfolio will be presented at the 52nd Annual Meeting of the American Society of Clinical...
Press Releases
Spark Therapeutics, Pfizer Inc announce data from initial subjects...
Subjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic Factor IX activity sustained...
Press Releases
Novartis announces FortiHFy clinical programme of Entresto
Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40 active or planned trials The...
Press Releases
AstraZeneca highlights continued progress of oncology pipeline at ASCO...
73 abstracts presented at ASCO with 19 related to Lynparza and new potential medicines targeting DNA damage response in multiple tumour typesContinued momentum of immuno-oncology...
Press Releases
Amgen Inc Data To Be Presented At ASCO 2016...
New Analysis From Phase 3 Trial of Kyprolis® (Carfilzomib) Combination Treatment in Relapsed Multiple Myeloma Patients With Early Disease ProgressionPhase 1/3 MASTERKEY-265 Study Abstracts Present...
Press Releases
Merck and Pfizer to Present Avelumab Data in Seven...
14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration between Merck KGaA, Darmstadt, Germany, and Pfizer Two oral presentations:...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.